2019
DOI: 10.1007/s11357-019-00090-2
|View full text |Cite
|
Sign up to set email alerts
|

Tamoxifen induction of Cre recombinase does not cause long-lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies

Abstract: The systemic delivery of tamoxifen (Tam) to activate inducible CreERT2-loxP transgenic mouse systems is now widely used in neuroscience studies. This critical technological advancement allows temporal control of DNA-cre recombination, avoidance of embryonically lethal phenotypes, and minimization of residual cell labeling encountered in constitutively active drivers. Despite its advantages, the use of Tam has the potential to cause long-lasting, uncharacterized side effects on the transcriptome and epigenome i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
44
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 21 publications
(50 citation statements)
references
References 87 publications
(109 reference statements)
6
44
0
Order By: Relevance
“…This is consistent with the concept that mCH is concentrated in neurons 1 and provides more specific detail that this is true when astrocytes or microglial alone are examined. As previously reported for the brain 14, 25, 26 , no non-CG hydroxymethylation (hmCH) was detected in any of the samples analyzed (Figure 7D) . To uncover potential cell type-specific differences in mCG patterns, methylation across cell-type marker genes (from −4kb in respect to the TSS and +4b from the TES) was compared for astrocytes (Figure 7E) and microglia (Figure 7H) .…”
Section: Resultssupporting
confidence: 84%
See 4 more Smart Citations
“…This is consistent with the concept that mCH is concentrated in neurons 1 and provides more specific detail that this is true when astrocytes or microglial alone are examined. As previously reported for the brain 14, 25, 26 , no non-CG hydroxymethylation (hmCH) was detected in any of the samples analyzed (Figure 7D) . To uncover potential cell type-specific differences in mCG patterns, methylation across cell-type marker genes (from −4kb in respect to the TSS and +4b from the TES) was compared for astrocytes (Figure 7E) and microglia (Figure 7H) .…”
Section: Resultssupporting
confidence: 84%
“…While it is sometimes simplistically believed hydroxymethylation and non-CpG methylation are restricted to neurons these findings provide evidence that while CG hydroxymethylation and non-CG methylation levels may be lower in non-neuronal cell populations yet they are not absent. To date, there is no explanation for why hydroxymethylation is not evident in the non-CG context but as previously reported this modification is absent or at a level below detection 14, 25 .…”
Section: Discussionmentioning
confidence: 86%
See 3 more Smart Citations